K
KLRA
Kailera Therapeutics
11.61
+1.61+16.10%Pre Market: 11.69 +0.08 +0.69%04:39 10/12 EDT
OPEN/PREV CLOSE10.64/10.77
TODAY RANGE10.44-10.99
VOL47
MARKET CAP1.39B
52 WEEK RANGE9.76-28.23
AVG VOL (3M)925.93K
% TURNOVER0.88%
TURNOVER--
P/E (TTM)-6.2207
% RANGE5.11%
EPS(TTM)-1.7265
P/E(FORWARD)-2.5850
P/B1.245
BVPS8.63
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP948.16M
SHARES OUTSTANDING129.64M
NEXT EARNINGS--
FREE FLOAT88.28M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·10/02 20:34
Oversold Conditions For Kailera Therapeutics (KLRA)
TipRanks·10/02 12:36
Seven new option listings on October 2nd
Seeking Alpha·10/02 08:21
GLP-1s: Still Early In The Growth Story
TipRanks·10/01 10:55
Kailera Therapeutics announces positive results from several presentations
TipRanks·09/30 11:10
Kailera announces completion of enrollment in KaiNETIC Phase 3 program
TipRanks·09/30 09:05
TD Cowen Sticks to Its Buy Rating for Kailera Therapeutics, Inc. (KLRA)
Seeking Alpha·09/18 19:02
Kailera Therapeutics: Hold Due To Need For Progress On Weight Loss Differentiation
Seeking Alpha·09/17 15:42
Kailera Therapeutics: An Outside Biotech Bet For The Next GLP-1 Obesity Drug Approval
Benzinga·09/11 12:49
Jim Cramer Recommends Buying This Energy Stock, Calling It ‘Very Inexpensive’
TipRanks·09/07 18:33
3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts
Seeking Alpha·08/27 23:09
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)
NASDAQ·08/16 20:20
2 GLP-1 Stocks That Could Double Your Money by 2031
Same Industry
Name/Symbol
Change%
Price